Filing Details

Accession Number:
0000899243-22-013966
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-05 21:16:44
Reporting Period:
2022-04-01
Accepted Time:
2022-04-05 21:16:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1665988 Bioventus Inc. BVS Surgical & Medical Instruments & Apparatus (3841) 810980861
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835184 Anthony D'adamio 4721 Emperor Boulevard, Suite 100
Durham NC 27703
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-04-01 37,476 $0.00 56,148 No 4 M Direct
Class A Common Stock Disposition 2022-04-04 16,016 $11.19 40,132 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Units Disposition 2022-04-01 37,476 $0.00 37,476 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  2. Reflects shares sold to cover taxes upon the vesting of RSUs on April 1, 2022 pursuant to a standing 10b5-1 instruction.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.0438 to $11.54, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The RSUs vested on April 1, 2022.